Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Diabetic Ulcers Treatment Market

Diabetic Ulcers Treatment Market Analysis

  • Report ID: GMI6078
  • Published Date: Jun 2023
  • Report Format: PDF

Diabetic Ulcers Treatment Market Analysis

The wound care dressings segment held 54% share of the diabetic ulcers treatment market in 2022. Wound care dressings are most widely used in the treatment of diabetic ulcers. These dressing provide a barrier that shields the wound from dirt, bacteria, and other harmful microorganisms, thereby helping to prevent infection and promotes faster healing. Also, wound dressings such as hydrocolloid or hydrogel dressings help maintain an optimal moisture balance in the wound by absorbing excess exudate from the wound or provide moisture to dry wounds, creating a suitable environment for healing. Such aforementioned factors will promote high segmental growth.
 

Diabetic Ulcers Treatment Market Revenue Share, By Ulcer Type,

The foot ulcer segment dominated the industry 88.8% share in 2022. High incidence of diabetic foot ulcers amongst diabetic patients aids in segmental growth. For example, as per the Diabetic foot epidemiology and demographics 2021, the incidence of diabetic foot ulcer is approximately 630 per 100,000 diabetic individuals worldwide. Similarly, as per the CDC, 12% of people with diabetes develop diabetic foot ulcers during their lifetime. Such high incidence of diabetic foot ulcers will supplement the business growth over the analysis period.
 

The hospitals sector led the diabetic ulcers treatment market with dominant valuation in 2022. Availability of specialized care in hospitals, patient cantered approach, well developed infrastructure, and easy access increase the flow of patients in hospitals. Also, favourable reimbursement scenarios, multidisciplinary approach, and the convenience of receiving various treatments or procedures under one roof in hospital settings attract patients to hospitals, thereby augmenting the sector growth.
 

North America Diabetic Ulcers Treatment Market Size,

North America diabetic ulcers treatment industry amassed over 38.3% market share in 2022 and is speculated to grow at considerable growth rate between 2023 and 2032. Flourishing market expansion can be attributed to the increasing prevalence of diabetes in the region. Diabetes rates have been rising steadily in North America due to factors such as sedentary lifestyles, unhealthy eating habits, and an aging population.
 

Also, advancements in medical technology and treatment options have improved the management and outcomes of diabetic ulcers. Similarly, awareness campaigns, educational initiatives, and improved understanding of diabetes management among healthcare professionals and patients aids in early detection and treatment of diabetic ulcers, thereby propelling the regional diabetic ulcers treatment market statistics.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of diabetic ulcers treatment reached USD 9.3 billion in 2022 and will grow at over CAGR 5.8% CAGR from 2023 to 2032 attributed to the rise in the diabetic population continues.

The foot ulcer segment dominated the diabetic ulcers treatment market in 2022 with a industry share of 88.8%, owing to high incidence of diabetic foot ulcers amongst diabetic patients.

North America diabetic ulcers treatment industry accounted for over 38.3% revenue share in 2022 and will continue to grow over 2023-2032, due to rising diabetes rate in the region due to factors such as sedentary lifestyles, unhealthy eating habits, and an aging population.

B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis Holdings Inc., Derma Sciences Inc., Integra LifeSciences, Hill Rom Holdings Inc., M

Diabetic Ulcers Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 439
  • Countries covered: 20
  • Pages: 225
 Download Free Sample